Skip to main content

Table 1 Description of baseline characteristics of HIV-infected infants treated by cART for at least 3 months (ANRS-PEDIACAM Study, 2008-2013, Cameroon)

From: Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

 

N = 167

Variables (n, % of missing data)

N

% (n) or median (IQR)

Male sex

167

45.5 (76)

Infant group at inclusion

167

 

 Followed since birth

 

37.7 (63)

 Not followed since birth but diagnosed before age 7 months

 

62.3 (130)

Recruitment sites

167

 

 CME/FCB

 

47.3 (79)

 HLD

 

23.4 (39)

 CHE

 

29.3 (49)

History of breastfeeding

110

51.8 (57)

Vital status of parents at cART initiation

167

 

 Mother dead

 

6.6 (11)

 Father dead

 

3.6 (6)

 Vital status of the father unknown (or data missing)

 

6.6 (11)

Infants living with:

167

 

 Both parents

 

50.3 (84)

 Mother only

 

37.7 (63)

 Other caregivers

 

12.0 (20)

Presence of functional fridge at home

115

43.5 (50)

Difficulty with remembering to give cART medication

  

 M3

138

33.3 (46)

 M12

123

24.4 (30)

 M24

81

29.6 (24)

Clinical status at cART initiation

167

 

 WAZ (median, IQR)

 

−0.2 (−0.4; −0.1)

 History of hospitalization

 

41.3 (69)

CD4 count (%) at cART initiation (median, IQR)

161

23 (15 ; 32)

Viral load at cART initiation (log10 cp/mL) (median, IQR)

166

6.5 (6.0 ; 6.9)

Age at cART initiation

167

 

  < 6 months

 

80.8 (135)

 6–12 months

 

16.8 (28)

  > 12 months

 

2.4 (4)

 In months (median, IQR)

 

4.0 (3.0–9.0)

Type of first cART

167

 

 Protease inhibitor-based regimen

 

63.9 (110)

 Nevirapine-based regimen

 

34.1 (57)

  1. N total number, n number of children in the group, CME/FCB Centre Mère et Enfant/Fondation Chantal Biya, Yaounde, HLD Hôpital Laquintinie, Douala, CHE Centre Hospitalier d’Essos, Yaounde, Mx delay from cART initiation to the current visit, e.g. «M3» means «3 months after cART initiation», cART combination antiretroviral therapy, % percentage, n number of patients in the cell, WAZ Weight for Age Z score based on WHO reference tables, IQR interquartile range, CD4 lymphocytes that have CD4 marker